FDA ustekinumab coverage for business development, investment, and market access teams
Earlier
Standard impact AnalysisApr 29, 2026
Rise of Biosimilars in US: FDA Approval Trends & Market Impact
FDA · oncology · 13 min
Dr. Amina FaroukHigh impact NewsApr 8, 2026
FDA Approves Stelara: New Ulcerative Colitis Treatment from J&J
FDA · Ulcerative Colitis · 4 min
Dr. Sarah MitchellHigh impact NewsApr 1, 2026
FDA Approves First Interchangeable Biosimilar for Stelara (Ustekinumab)
FDA · autoimmune diseases · 5 min
Dr. Sarah MitchellPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways